ArticleLeukemia2018

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.

S K Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.